Ozurdex for Retinal Vein Occlusion Study (ORVO Study)

NCT01790685 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
40
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Johns Hopkins University

Collaborators